Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
3.830
+0.020 (0.52%)
Sep 25, 2026, 4:00 PM EDT - Market closed
Relmada Therapeutics Employees
Relmada Therapeutics had 17 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
17
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$3,642,670
Market Cap
408.55M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 17 | 0 | - |
| Dec 31, 2024 | 17 | -3 | -15.00% |
| Dec 31, 2023 | 20 | 6 | 42.86% |
| Dec 31, 2022 | 14 | 4 | 40.00% |
| Dec 31, 2021 | 10 | -4 | -28.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ARS Pharmaceuticals | 200 |
| Editas Medicine | 87 |
| Larimar Therapeutics | 71 |
| Rezolute | 68 |
| Zura Bio | 40 |
| DiaMedica Therapeutics | 35 |
| Inhibikase Therapeutics | 35 |
| Opus Genetics | 28 |
RLMD News
- 24 days ago - Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Relmada Therapeutics reports Q2 EPS (11c), consensus (20c) - TheFly
- 7 weeks ago - Relmada Therapeutics Earnings Call Transcript: Q2 2026 - Transcripts
- 7 weeks ago - Relmada Therapeutics Quarterly report: Q2 2026 - Filings
- 7 weeks ago - Relmada Therapeutics Earnings release: Q2 2026 - Filings
- 1 month ago - Relmada Therapeutics appoints Bipin Dalmia as chief business officer - TheFly
- 1 month ago - Relmada Therapeutics names Bipin Dalmia chief business officer - TheFly
- 1 month ago - Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer - GlobeNewsWire